TRexBio

formerly Trex Bio

TRexBio is a biotech company in South San Francisco, United States, founded in 2018. It has raised $219.0M across 4 rounds, most recently a $50.0M Extension Round in January 2026.

TRex Bio

Employees
11–50
Founded
2018
Business Model
B2B
Website
trex.bio
Total Funding
$219.0M
Last Round
$50.0M Extension RoundJan 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 12 investors for this company. The full record is or through the API.

About

TRexBio is a South San Francisco-based clinical-stage biotechnology company developing purpose-built biologics that restore immune balance in autoimmune and inflammatory diseases. Founded in 2018 with seed funding from SV Health Investors, TRexBio's platform leverages deep tissue biology to design biologics capable of selectively modulating immune responses. The company raised M in a Series B extension in January 2026 to advance its pipeline including programs for atopic dermatitis.

Summary

It lists 11–50 employees. It has raised $219.0M in total across 4 rounds, most recently a $50.0M Extension Round in Jan 2026. Investors include Delos Capital, Polaris Partners and SV Health Investors.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension RoundJan 2026
$50.0M

Sign up to see all 4 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TRexBio on Indexed.vc
<a href="https://indexed.vc/companies/trex-bio"><img src="https://indexed.vc/api/badge/company/trex-bio" alt="TRexBio on Indexed.vc" width="260" height="76" /></a>